Tharimmune (THAR) received feedback from a Scientific Advice meeting with the European Medicines Agency that included guidance on a planned ...
Eli Lilly's Ebglyss improves skin and itch symptoms in eczema patients, including Dupixent-treated cases, with positive Phase ...
A recent literature review presents a range of causes and treatments for chronic pruritus, including more novel options and a disease schematic for clinical decision support. The review has been ...
A panel of dermatologists and plastic surgeons created a consensus statement on the use of intralesional corticosteroids in patients with keloids.
The ADapt study assessed the efficacy and safety of EBGLYSS in individuals who had previously been treated with dupilumab.
Mirum Pharmaceuticals, Inc. today announced its participation in the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) annual meeting taking place November ...
Tinea infections are quite common in the general population as well, but in homeless people they often represent a portal of entry for fungal and bacterial pathogens that, in the setting of ...
In addition to the currently approved indications, Regeneron and Sanofi are studying dupilumab in a broad range of diseases driven by type 2 inflammation or other allergic processes in Phase 3 trials, ...
The court heard how conditions at the property were dire, with pawprints and faeces covering the cooking appliances ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback